{"filing":{"accession_number":"0001279569-26-000747","cik":"0001683541","ticker":"ACB","company_name":"AURORA CANNABIS INC","form":"6-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"aurora_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1683541/000127956926000747/aurora_6k.htm"},"events":[{"id":24810,"run_id":22496,"accession_number":"0001279569-26-000747","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a news release dated August 5, 2026, announcing Aurora Cannabis's fiscal 2027 first quarter financial results for the period ending June 30, 2026. The exhibit discloses consolidated net revenue of $67.6 million, gross profit, operating expenses, net loss from continuing operations of $4.0 million, adjusted EBITDA of $3.4 million, and free cash flow metrics, along with segment performance (medical cannabis, consumer cannabis, wholesale bulk cannabis). The release includes management commentary on operational performance and forward-looking guidance. This is a classic earnings release disclosing quarterly financial results.","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-08-05","form":"6-K","submitted_at":null,"items":[{"id":25489,"accession_number":"0001279569-26-000747","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a news release dated August 5, 2026, announcing Aurora Cannabis's fiscal 2027 first quarter financial results for the period ending June 30, 2026. The exhibit discloses consolidated net revenue of $67.6 million, gross profit, operating expenses, net loss from continuing operations of $4.0 million, adjusted EBITDA of $3.4 million, and free cash flow metrics, along with segment performance (medical cannabis, consumer cannabis, wholesale bulk cannabis). The release includes management commentary on operational performance and forward-looking guidance. This is a classic earnings release disclosing quarterly financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:23:35.136294+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25489,"accession_number":"0001279569-26-000747","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a news release dated August 5, 2026, announcing Aurora Cannabis's fiscal 2027 first quarter financial results for the period ending June 30, 2026. The exhibit discloses consolidated net revenue of $67.6 million, gross profit, operating expenses, net loss from continuing operations of $4.0 million, adjusted EBITDA of $3.4 million, and free cash flow metrics, along with segment performance (medical cannabis, consumer cannabis, wholesale bulk cannabis). The release includes management commentary on operational performance and forward-looking guidance. This is a classic earnings release disclosing quarterly financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:23:35.136294+00:00","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-08-05"}]}